IL-12 can also induce IFNγ-independent CRC tumour rejection via activation of CD8+ T cells, a process that is dependent on CD4+ T cells and granulocyte-macrophage colony-stimulating factor (GM-CSF) [84]. The gene discussed is CD8A; the disease is neoplasm.